The sphingolipid receptor S1PR2 is a receptor for Nogo-a repressing synaptic plasticity

PLoS Biol. 2014 Jan;12(1):e1001763. doi: 10.1371/journal.pbio.1001763. Epub 2014 Jan 14.

Abstract

Nogo-A is a membrane protein of the central nervous system (CNS) restricting neurite growth and synaptic plasticity via two extracellular domains: Nogo-66 and Nogo-A-Δ20. Receptors transducing Nogo-A-Δ20 signaling remained elusive so far. Here we identify the G protein-coupled receptor (GPCR) sphingosine 1-phosphate receptor 2 (S1PR2) as a Nogo-A-Δ20-specific receptor. Nogo-A-Δ20 binds S1PR2 on sites distinct from the pocket of the sphingolipid sphingosine 1-phosphate (S1P) and signals via the G protein G13, the Rho GEF LARG, and RhoA. Deleting or blocking S1PR2 counteracts Nogo-A-Δ20- and myelin-mediated inhibition of neurite outgrowth and cell spreading. Blockade of S1PR2 strongly enhances long-term potentiation (LTP) in the hippocampus of wild-type but not Nogo-A(-/-) mice, indicating a repressor function of the Nogo-A/S1PR2 axis in synaptic plasticity. A similar increase in LTP was also observed in the motor cortex after S1PR2 blockade. We propose a novel signaling model in which a GPCR functions as a receptor for two structurally unrelated ligands, a membrane protein and a sphingolipid. Elucidating Nogo-A/S1PR2 signaling platforms will provide new insights into regulation of synaptic plasticity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Proliferation
  • GTP-Binding Protein alpha Subunits, G12-G13 / genetics
  • GTP-Binding Protein alpha Subunits, G12-G13 / metabolism
  • Gene Expression Regulation
  • Hippocampus / cytology
  • Hippocampus / metabolism*
  • Long-Term Potentiation
  • Lysophospholipids / metabolism
  • Mice
  • Mice, Knockout
  • Motor Cortex / cytology
  • Motor Cortex / metabolism*
  • Myelin Proteins / deficiency
  • Myelin Proteins / genetics*
  • Myelin Sheath / genetics
  • Myelin Sheath / metabolism
  • Neurites / metabolism
  • Neuronal Plasticity / genetics*
  • Nogo Proteins
  • Proprotein Convertases / genetics
  • Proprotein Convertases / metabolism
  • Receptors, Lysosphingolipid / antagonists & inhibitors
  • Receptors, Lysosphingolipid / genetics*
  • Receptors, Lysosphingolipid / metabolism
  • Serine Endopeptidases / genetics
  • Serine Endopeptidases / metabolism
  • Signal Transduction
  • Sphingosine / analogs & derivatives
  • Sphingosine / metabolism
  • Sphingosine-1-Phosphate Receptors
  • Synapses / metabolism
  • rho GTP-Binding Proteins / genetics
  • rho GTP-Binding Proteins / metabolism
  • rhoA GTP-Binding Protein

Substances

  • Lysophospholipids
  • Myelin Proteins
  • Nogo Proteins
  • Receptors, Lysosphingolipid
  • Rtn4 protein, mouse
  • Sphingosine-1-Phosphate Receptors
  • sphingosine-1-phosphate receptor-2, mouse
  • sphingosine 1-phosphate
  • Proprotein Convertases
  • Serine Endopeptidases
  • membrane-bound transcription factor peptidase, site 1
  • GTP-Binding Protein alpha Subunits, G12-G13
  • RhoA protein, mouse
  • rho GTP-Binding Proteins
  • rhoA GTP-Binding Protein
  • Sphingosine

Grants and funding

This work was supported by the Swiss National Science Foundation (grants 3100A0-122527/1 and 310030B-138676/1), the ERC advanced grant 294115, the National Centre for Competence in Research “Neural Plasticity and Repair” of the Swiss National Science Foundation, and the International Foundation for Research in Paraplegia IFP Zurich. MZ and MK are supported by the Deutsche Forschungsgemeinschaft (ZA 554-2-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.